CVS CVS HEALTH Earnings and EPS analysis

EPS in 2026 (TTM): $2.32

Last Report Period Date: Mar 31, 2026

As of June 2026, according to CVS HEALTH's latest financial report, the company's current EPS (TTM) is $2.32. In 2025, the company recorded an earnings per share (EPS) of $1.4, which represents a decrease compared to its EPS of $3.67 in 2024. CVS HEALTH's earnings per share for the quarterly report ending on Mar 31, 2026 was $2.31.

The annual EPS in 2025 was $1.4, a decrease of 61.9% from $3.67 in 2024. For the quarter ending Mar 31, 2026, the EPS was $2.31, showing a 63.8% increase from the same quarter last year. The trailing twelve months (TTM) EPS as of March 2026 is $2.32. In 2024, the annual EPS was $3.67, showing a decrease of 43.5% from 2023.

Over the last 12 months, CVS HEALTH has registered an EPS growth of 63.8% (YoY, quarterly). Over a three-year span, the company had an average EPS growth of -24.8% per year. Over the last 5 years, the company had an average EPS growth rate of -23.9%. When measured over a ten-year period, CVS's average EPS growth rate was -11.3%.